68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience. - Wikidata - awgldk - TriplyDB

68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.

68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.

http://www.wikidata.org/entity/Q37554235

about

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.Current status of theranostics in prostate cancer.Imaging Characteristics and First Experience of [68Ga]THP-PSMA, a Novel Probe for Rapid Kit-Based Ga-68 Labeling and PET Imaging: Comparative Analysis with [68Ga]PSMA I&T.PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer.[The role of PSMA PET-CT in patients with metastatic prostate cancer].[The role of PSMA PET-CT in patients with metastatic prostate cancer].PSMA Theranostics: Current Status and Future Directions.PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.Clinical perspectives of PSMA PET/MRI for prostate cancer Positron emission tomography in prostate cancer: An update on state of the art

P2860

Q33841484-7BD43629-C7AA-47F4-8132-90A35706BCB5 Q41475179-19484513-1A54-4249-A06A-17CF2C9A6F8E Q47107456-2377F136-7A70-4F0F-B81A-9065B1B02A09 Q47241139-859DCFCE-83E0-4C33-A3C2-2DDEB08879F8 Q48221776-1EA8D6AF-1409-482A-BD47-C222BC33D0A6 Q48297324-6944F4EA-DFE3-48DE-B36C-24CD38D69297 Q49589359-EC813A8C-0470-449F-B732-09BB22B121FC Q49981290-B1E6A4E2-C64A-4CCC-9B53-64C01E506AFB Q55023828-782B89C9-B3C6-4099-B868-612ABF7E0A9B Q55399763-49284160-2399-44E2-A232-49E7AEF488A1 Q57071079-B483DECD-6C90-4751-AF98-DB0248BE6F5A Q57110351-E48CD5D6-E2E7-4D45-990E-4C3803E176B1

P2860

68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.

http://www.wikidata.org/entity/Q37554235

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

68Ga-PSMA-11 PET Imaging of Re ...... ition: First Human Experience.

@en

68Ga-PSMA-11 PET Imaging of Re ...... ition: First Human Experience.

@nl

type

label

68Ga-PSMA-11 PET Imaging of Re ...... ition: First Human Experience.

@en

68Ga-PSMA-11 PET Imaging of Re ...... ition: First Human Experience.

@nl

prefLabel

68Ga-PSMA-11 PET Imaging of Re ...... ition: First Human Experience.

@en

68Ga-PSMA-11 PET Imaging of Re ...... ition: First Human Experience.

@nl

P1433

Q37554235-D079A9F1-D05D-4B26-AE81-6F7999516E1E

P1476

Q37554235-59BA6C94-6497-429C-B584-4123E8649354

P2093

Q37554235-084A5692-47DD-42E5-8480-E18EC4939D22

Q37554235-340DE1EB-4410-440C-B70A-315AFAF78B3A

Q37554235-6F7DB2F1-1A25-402D-89B9-7ED3838DEB29

Q37554235-7590DC63-9956-442E-ABBB-B57C20C43407

Q37554235-765CF18F-C159-43C1-A271-A7972F85D460

Q37554235-7E24F3D8-B339-47C1-8E48-436258E7F78D

Q37554235-86364C13-6031-4542-87B2-A0147B6D1D27

P2860

Q37554235-0E260F56-E4C1-412B-913E-5422CF00BC25

Q37554235-157AB9D9-F997-4423-9D0F-94452F0E4276

Q37554235-21B7A35D-FE79-4CED-AAA0-4DA91B2F5366

Q37554235-26308119-9911-4C29-87C7-F1B87CC064AD

Q37554235-2A34FD25-A2F7-4DDA-977D-2FAAB4FA66EA

Q37554235-39B3CDC0-4937-4399-BDE8-414B629C2FFB

Q37554235-4D9E034E-B286-4AD3-90F8-A84C91D8F286

Q37554235-55100C0A-583A-441D-9F99-883668339C94

Q37554235-595A08E5-D028-4E58-A03A-8F4F13761236

Q37554235-6416C314-4D21-4AC1-9B83-538AA209FDB7

P304

Q37554235-0714A3C8-6E3F-4F4A-BE94-903C47411F09

P31

Q37554235-C73DA8A9-9C7B-4D6F-97A7-E0C384BAB766

P356

Q37554235-19E7121D-DBC8-440A-A234-335AAB1771F6

P407

Q37554235-31DA59D3-7FCE-449A-A0C8-BADD72034317

P433

Q37554235-59C5A5B4-EBFD-4FA0-8B7C-7B123FFB4C94

P478

Q37554235-844CD48E-D8B6-47F4-B65B-66F4297C1CA2

P50

Q37554235-9DCC4DFA-8715-40F4-B3C2-67A7A0C89EC0

Q37554235-DDB38F6E-3F08-473D-951B-BB4E536006E5

P577

Q37554235-2453F7FC-B09A-4D7C-B17F-9639D5A95FE4

P698

Q37554235-C93237B8-9F0A-4898-BBE9-35550868A340

P932

Q37554235-75EB8C5E-8B7E-44D9-A468-9B06998437A6

P356

JNUMED.116.181800

P1433

The Journal of Nuclear Medicine

P1476

68Ga-PSMA-11 PET Imaging of Re ...... bition: First Human Experience

@en

P2093

Charles J Ryan

http://www.w3.org/2001/XMLSchema#string

Eric C Ehman

http://www.w3.org/2001/XMLSchema#string

Eric J Small

http://www.w3.org/2001/XMLSchema#string

Michael J Evans

http://www.w3.org/2001/XMLSchema#string

Peter R Carroll

http://www.w3.org/2001/XMLSchema#string

Rahul Aggarwal

http://www.w3.org/2001/XMLSchema#string

Thomas A Hope

http://www.w3.org/2001/XMLSchema#string

P2860

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.

Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.

Androgen deprivation therapy for prostate cancer: current status and future prospects.

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Androgen deprivation therapy for prostate cancer.

Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

Measuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer.

Prostate-specific membrane antigen-based imaging.

P304

81-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.116.181800

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Charles Truillet

Ali Afshar-Oromieh

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27660139

http://www.w3.org/2001/XMLSchema#string

P932

5209643

http://www.w3.org/2001/XMLSchema#string